On this page

Anktiva

nogapendekin alfa inbakicept-pmln

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Anktiva

Proper name

nogapendekin alfa inbakicept-pmln

Licence type

351(a)

BLA number

761336

Applicant

Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.

Center

CDER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
400MCG/0.4ML	Solution	Intravesical	Single-Dose Vial	Rx	April 22, 2024

Purple Book	FDA	Licence type, presentations, reference product, exclusivity